GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (XCNQ:MYCO) » Definitions » Cyclically Adjusted FCF per Share

Mydecine Innovations Group (XCNQ:MYCO) Cyclically Adjusted FCF per Share : C$-32.20 (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mydecine Innovations Group's adjusted free cash flow per share for the three months ended in Sep. 2023 was C$-0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$-32.20 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-10), Mydecine Innovations Group's current stock price is C$0.015. Mydecine Innovations Group's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 was C$-32.20. Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF of today is .


Mydecine Innovations Group Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Mydecine Innovations Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Cyclically Adjusted FCF per Share Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -32.20

Competitive Comparison of Mydecine Innovations Group's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF falls into.



Mydecine Innovations Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mydecine Innovations Group's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.003/125.2304*125.2304
=-0.003

Current CPI (Sep. 2023) = 125.2304.

Mydecine Innovations Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201311 0.000 97.182 0.000
201402 0.000 98.051 0.000
201405 -2.500 99.394 -3.150
201408 0.000 99.315 0.000
201412 0.000 98.367 0.000
201503 -33.667 99.789 -42.250
201506 -16.280 100.500 -20.286
201509 -5.741 100.421 -7.159
201512 -1.370 99.947 -1.717
201603 -3.185 101.054 -3.947
201606 -4.286 102.002 -5.262
201609 -1.100 101.765 -1.354
201612 -26.128 101.449 -32.253
201703 -23.939 102.634 -29.210
201706 -20.857 103.029 -25.351
201709 -2.845 103.345 -3.447
201712 -37.090 103.345 -44.945
201803 -10.978 105.004 -13.093
201806 -25.769 105.557 -30.572
201809 -6.103 105.636 -7.235
201812 0.362 105.399 0.430
201903 -5.020 106.979 -5.876
201906 -0.652 107.690 -0.758
201909 -1.142 107.611 -1.329
201912 -0.239 107.769 -0.278
202003 -0.024 107.927 -0.028
202006 -1.483 108.401 -1.713
202009 -0.543 108.164 -0.629
202012 -0.859 108.559 -0.991
202103 -2.190 110.298 -2.486
202106 -0.980 111.720 -1.099
202109 -1.246 112.905 -1.382
202112 -0.955 113.774 -1.051
202203 -0.350 117.646 -0.373
202206 -0.570 120.806 -0.591
202209 -0.052 120.648 -0.054
202212 -0.084 120.964 -0.087
202303 -0.162 122.702 -0.165
202306 -0.085 124.203 -0.086
202309 -0.003 125.230 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Mydecine Innovations Group  (XCNQ:MYCO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mydecine Innovations Group Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (XCNQ:MYCO) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Executives
David Joshua Bartch Director

Mydecine Innovations Group (XCNQ:MYCO) Headlines

No Headlines